Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
52,506
Sort by:
2024 Clinical Chemistry and Immunodiagnostic Markets: US, Europe, Japan--Supplier Shares and Strategies, Sales Forecasts by Country, Emerging Tests, Innovative Technologies, Instrumentation Review, Profiles of Leading Competitors
US$ 7,500.00
This new 464-page report from VPGMarketResearch provides analysis of the global clinical chemistry and immunodiagnostic markets, including emerging tests, technologies, instrumentation, sales forecas...
September 2024
-
2024 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Test, Emerging Technologies, Latest Instrumentation
US$ 14,500.00
This comprehensive five-country report contains 900 pages and 335 tables. The report explores future trends in the European countries (France, Germany, Italy, Spain, UK); provides estimates of the sp...
September 2024
-
2024 Europe Drugs of Abuse Testing Market for 12 Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Profiles of Leading Competitors
US$ 4,500.00
This new 300-page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecast...
September 2024
-
2024 Europe Endocrine Function Testing Market for 20 Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Profiles of Leading Competitors
US$ 5,500.00
This new 35-page report from LeadingMarketResearch provides a comprehensive analysis of the European endocrine function market, including emerging tests, technologies, instrumentation, sales forecast...
September 2024
-
2024 Europe Immunoprotein Testing Market for 13 Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Profiles of Leading Competitors
US$ 4,500.00
This new 273-page report from VPGMarketResearch provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market sha...
September 2024
-
2024 Europe Therapeutic Drug Monitoring (TDM) Market for 28 Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Profiles of Leading Competitors
US$ 5,500.00
This new 291-page report from LeadingMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sale...
September 2024
-
